XLVI vs. XPH
XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) and XPH (SPDR S&P Pharmaceuticals ETF) are both exchange-traded funds - XLVI is a Derivative Income fund actively managed by State Street, while XPH is a Health & Biotech Equities fund tracking the S&P Pharmaceuticals Select Industry Index. XLVI is actively managed, while XPH is passively managed. A 0.54 correlation means they provide meaningful diversification when combined. Both charge a 0.35% expense ratio.
Performance
XLVI vs. XPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XLVI achieves a -0.67% return, which is significantly lower than XPH's 0.66% return.
XLVI
- 1D
- 0.67%
- 1M
- 2.30%
- YTD
- -0.67%
- 6M
- 0.76%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XPH
- 1D
- 1.10%
- 1M
- -4.74%
- YTD
- 0.66%
- 6M
- 4.44%
- 1Y
- 37.98%
- 3Y*
- 13.07%
- 5Y*
- 3.50%
- 10Y*
- 3.44%
XLVI vs. XPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | -0.67% | 12.79% |
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 33.73% |
Correlation
The correlation between XLVI and XPH is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jul 31, 2025 | 0.54 |
XLVI vs. XPH - Sectors Allocation Comparison
Sectors
XLVI
XPH
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Healthcare
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Financial Services
XLVI
XPH
-
Basic Materials
XLVI
-
XPH
-
Communication Services
XLVI
-
XPH
-
Consumer Cyclical
XLVI
-
XPH
-
Consumer Defensive
XLVI
-
XPH
-
Energy
XLVI
-
XPH
-
Healthcare
XLVI
-
XPH
Industrials
XLVI
-
XPH
-
Real Estate
XLVI
-
XPH
-
Technology
XLVI
-
XPH
-
Utilities
XLVI
-
XPH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XLVI vs. XPH — Risk / Return Rank
XLVI
XPH
XLVI vs. XPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR Premium Income ETF (XLVI) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| XLVI | XPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 1.77 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.17 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.16 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.33 | 0.38 | +0.94 |
Drawdowns
XLVI vs. XPH - Drawdown Comparison
The maximum XLVI drawdown since its inception was -8.14%, smaller than the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for XLVI and XPH.
Loading charts...
Drawdown Indicators
| XLVI | XPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -8.14% | -48.03% | +39.89% |
Max Drawdown (1Y)Largest decline over 1 year | — | -11.97% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -23.57% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -31.63% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.97% | — |
Current DrawdownCurrent decline from peak | -4.02% | -7.22% | +3.20% |
Average DrawdownAverage peak-to-trough decline | -1.95% | -17.25% | +15.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 3.35% | — |
Volatility
XLVI vs. XPH - Volatility Comparison
Loading charts...
Volatility by Period
| XLVI | XPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 7.03% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 16.77% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 10.94% | 21.52% | -10.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 10.94% | 20.84% | -9.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 10.94% | 22.10% | -11.16% |
XLVI vs. XPH - Expense Ratio Comparison
Both XLVI and XPH have an expense ratio of 0.35%.
Dividends
XLVI vs. XPH - Dividend Comparison
XLVI's dividend yield for the trailing twelve months is around 11.53%, more than XPH's 0.66% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 11.53% | 5.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
XLVI and XPH have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
XLVI and XPH have the same expense ratio: 0.35% per year.
XLVI has the higher dividend yield at 11.53%, compared with 0.66% for XPH.
XLVI is categorized as Derivative Income, while XPH is Health & Biotech Equities.
Find the right allocation for XLVI and XPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer